# 68Ga-DOTATATE PET for Management of Neuroendocrine Tumors

> **NCT03873870** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 1916 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga -DOTATATE PET scans

## Key facts

- **NCT ID:** NCT03873870
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-28
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 1916 (ACTUAL)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03873870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03873870, "68Ga-DOTATATE PET for Management of Neuroendocrine Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03873870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*